13 algorithm-development-"Multiple"-"Prof"-"Prof"-"Simons-Foundation" research jobs at Nature Careers in France
Sort by
Refine Your Search
-
molecular targets critical for developing new therapies for rare diseases, based on genetic data and biological system simulations. -Computational Drug Repurposing: Developing novel algorithms and databases
-
Background: The nuclear oncology team has a long-lasting expertise in the development of targeted alpha therapy and is internationally recognized for its research on astatine-211 labeling chemistry
-
to drive progress in translational medicine, improving diagnostics and healthcare solutions. For more information, please visit our page. You will be the scientific liaison for a team developing secure and
-
We are recruiting a highly motivated and experienced researcher to develop and structure a research and educational program dedicated to kidney cancer. The position is supported by a 3-5 year fixed
-
across six sites in Heidelberg (headquarters), Barcelona, Cambridge, Grenoble, Hamburg and Rome. Our mission is to perform basic research in molecular biology; train scientists, students and visitors
-
contribute to the development of the Institute’s academic programs, mainly aimed at master's students, but also for bachelor's degrees, on-the-job training and MOOCs. The applicant will participate in
-
A post-doctoral position in human population genomics is opening in our lab to work on the POPGEN project. The POPGEN project is a pilot research project developed in the framework of the French
-
well as computational modeling. The development and numerical implementation of novel methods has become a key issue in modern oncology, both in terms of understanding the biology of cancers and for medical oncology
-
, but are not limited to, neural coding in the visual cortex, multimodal information processing, state-dependent processing, visual perception, development of imaging tools for in vivo neuronal recordings
-
The project will be developed in the host laboratory(SIMHEL/U978) whose main pathophysiological models are two CD5+chronic B cell neoplasms (chronic lymphocytic leukemiaand mantle cell lymphoma